The Allstate is trading 4.56% lower at $235.59 in pre-market; no fresh company-specific announcement or clearly linked catalyst has surfaced.

  • The shares declined 0.42% on October 19; the broad-market picture is mixed, with no substantial same-direction move clearly accounting for the drop.
  • Recent coverage cites a Keefe, Bruyette & Woods downgrade and lower price target dated October 12, not a new catalyst for this move.
  • Third-quarter results are scheduled for November 4.